Skip to main content

Table 9 Ferric reducing antioxidant power (FRAP) of eugenol derivatives

From: Lead optimization for promising monoamine oxidase inhibitor from eugenol for the treatment of neurological disorder: synthesis and in silico based study

Compound/sample

IC50 (µg/mL)a

Sr. no

IC50 (µg/mL)a

5a

5.934 ± 0.053

13a

18.14 ± 0.001

5b

5.112 ± 0.009

13b

10.77 ± 0.026

7

9.142 ± 0.061

13c

14.63 ± 0.007

9a

7.234 ± 0.001

13d

12.45 ± 0.017

9b

9.912 ± 0.005

16

16.88 ± 0.099

11

9.126 ± 0.013

17

15.91 ± 0.003

Eugenol

10.627 ± 0.082

l-Ascorbic acid

8.112 ± 0.091

  1. aValue are expressed as mean ± SEM, n = 3
Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us